VEGFA and metastatic colorectal cancer: Bevacizumab (BVZ), a recombinant humanized monoclonal IgG antibody directed against the human vascular endothelial growth factor (VEGF), is commonly used in frontline to later lines of treatment in advanced or metastatic colorectal cancer (mCRC).1, 6